Jiang T, Osadchiy V, Weinberger JM, et al. Impact of the COVID-19 pandemic on patient preferences and decision-making for symptomatic urolithiasis. J Endourol. In press. https://doi.org/10.1089/end.2020.1141.
References
- Estimating the impact of COVID-19 on urology: data from a large nationwide cohort.Eur Urol Open Sci. 2021; 25: 52-56
Jiang T, Osadchiy V, Weinberger JM, et al. Impact of the COVID-19 pandemic on patient preferences and decision-making for symptomatic urolithiasis. J Endourol. In press. https://doi.org/10.1089/end.2020.1141.
- Decision making and treatment options in endourology post-coronavirus disease 2019—adapting to the future.Curr Opin Urol. 2021; 31: 109-114
Article info
Publication history
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide CohortEuropean Urology Open ScienceVol. 25
- PreviewThe impact of the coronavirus disease 2019 (COVID-19) pandemic on urology worldwide has been the subject of frequent speculation, but population-level estimates on changes in urology care are sparsely reported. Here, we use newly released data from a large USA-based cohort to provide further insight into the impact of the pandemic on our field. For a final cohort of 900,900 patient encounters in 418 hospitals, we describe an approximately 20% decrease in urology-specific emergency room (ER) visits (19.4%, 95% confidence interval [CI] 17.4–21.5%), admissions to a urology service (19.3%, 95% CI 13.7–24.9%), and ambulatory urology surgeries (22.9%, 95% CI 13.2–32.6%) during March 2020 relative to baseline.
- Full-Text
- Preview
- Reply to Tommy Jiang, Sriram V. Eleswarapu, and Vadim Osadchiy’s Letter to the Editor re: Patrick Lewicki, Spyridon P. Basourakos, Bashir Al Hussein Al Awamlh, et al. Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort. Eur Urol Open Sci 2021;25:52–6. Impact of the COVID-19 Pandemic on Kidney Stones: Matching Online Discussions to Real World DataEuropean Urology Open ScienceVol. 29
- PreviewWe read with great interest about the work by Jiang et al, which connects our findings from a large administrative database [1] to data from a patient forum on kidney stones [2]. Their study provides a plausible explanation for our findings and helps in understanding the various factors underpinning the decrease in urologic care observed across all US geographic regions in the early stages of the COVID-19 pandemic. Investigating epidemiologic phenomena using a variety of different sources, from “big data” analyses to patient reports and single-institution experiences, improves our ability to refine hypotheses, with the referenced work as a strong example.
- Full-Text
- Preview